de Leng

Research Staff Other

Strategic program(s):

Strategic program(s):

Contact

Recent publications

Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load Birgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, Jade M van Berge Henegouwen, Louisa R Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Joris van de Haar, Annemiek van Ommen-Nijhof, Marleen Kok, Paul Roepman, Anne M L Jansen, Wendy W J de Leng, Maja J A de Jonge, Ann Hoeben, Carla M L van Herpen, Hans M Westgeest, Lodewyk F A Wessels, Henk M W Verheul, Hans Gelderblom, Emile E Voest
Clinical cancer research : an official journal of the American Association for Cancer Research, 2024, vol. 30, p.3735-3746
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment Laurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia, Jade M van Berge Henegouwen, Gijs F de Wit, Louisa R Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Paul Roepman, Wendy W J de Leng, Anne M L Jansen, Myriam Chalabi, Carla M L van Herpen, Lot A Devriese, Frans L G Erdkamp, Mariette Labots, Maja J A de Jonge, Emile D Kerver, Adriaan D Bins, Lindsay V M Leek, Jessica C L Notohardjo, Alfonsus J M van den Eertwegh, Lodewyk F A Wessels, Henk M W Verheul, Hans Gelderblom, Joris van de Haar, Emile E Voest
Clinical cancer research : an official journal of the American Association for Cancer Research, 2024, vol. 30, p.4339-4351
Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas Saya Ahmad, Angelika Muhlebner, Tom J Snijders, Wendy W de Leng, Tatjana Seute, Rachel S van Leeuwaarde
Cancer, 2024, vol. 130, p.3473-3479
mRNA Expression Level of ALK in Neuroblastoma Is Associated with Histological Subtype, ALK Mutations and ALK Immunohistochemical Protein Expression Rixt S. Bruinsma, Marta F. Fiocco, Wendy W.J. de Leng, Lennart A. Kester, Karin P.S. Langenberg, Godelieve A.M. Tytgat, Max M. van Noesel, Marc H.W.A. Wijnen, Alida F.W. van der Steeg, Ronald R. de Krijger
Journal of Molecular Pathology, 2024, vol. 5, p.304-318